Detalles de la búsqueda
1.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34774225
2.
First-line immunotherapy versus targeted therapy in patients with BRAF-mutant advanced melanoma: a real-world analysis.
Future Oncol
; 17(6): 689-699, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084375
3.
Risk of cardiovascular events among patients with HIV treated with atazanavir-containing regimens: a retrospective cohort study.
BMC Infect Dis
; 16: 492, 2016 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27643691
4.
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
Immunotherapy
; 16(1): 29-42, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937397
5.
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.
Clin Cancer Res
; 29(17): 3352-3361, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058595
6.
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors.
Melanoma Res
; 32(1): 35-44, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34855329
7.
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
J Clin Oncol
; 40(2): 127-137, 2022 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818112
8.
Erratum to: Risk of cardiovascular events among patients with HIV treated with atazanavircontaining regimens: a retrospective cohort study.
BMC Infect Dis
; 16(1): 547, 2016 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27717332
9.
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067.
J Immunother Cancer
; 9(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799400
10.
Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison.
Immunotherapy
; 11(7): 617-629, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30852924
11.
Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma.
Immunotherapy
; 11(4): 283-295, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563395
12.
Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced Melanoma.
J Clin Oncol
; 37(35): 3350-3358, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31498030
13.
Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.
J Acquir Immune Defic Syndr
; 81(5): e141-e147, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31135582
14.
Sequential treatment approaches in the management of BRAF wild-type advanced melanoma: a cost-effectiveness analysis.
Immunotherapy
; 10(14): 1241-1252, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30175642
15.
Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
AIDS Res Hum Retroviruses
; 34(11): 916-921, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984593
16.
Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.
AIDS
; 31(15): 2095-2106, 2017 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28692532
17.
Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting.
J Med Econ
; 19(4): 386-96, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26640980
18.
Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review.
Infect Dis Ther
; 5(4): 473-489, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677263
19.
No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting.
J Int AIDS Soc
; 17(4 Suppl 3): 19538, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394047
Resultados
1 -
19
de 19
1
Próxima >
>>